Journal of Traditional Medical Complementary Therapies

.: REVIEW
Kahve Tüketiminin Obezite Tedavisinde Destekleyici Rolü
The Role of Coffee Consumption in the Treatment of Obesity
Melahat Sedanur MACİTa, Eda KÖKSALb
aOndokuz Mayıs Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Samsun, TÜRKİYE
bGazi Üniversitesi Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü, Ankara, TÜRKİYE
J Tradit Complem Med. 2020;3(1):119-27
doi: 10.5336/jtracom.2019-72433
Article Language: TR
Full Text
ÖZET
 Obezite, vücutta artmış yağ birikimiyle tanımlanan kronik bir hastalıktır. Obezite tedavisinde tıbbi beslenme tedavisi ve yaşam tarzı değişiklikleri tedavinin esas basamağını oluşturmaktadır. Ancak, son yıllarda obezite tedavisini destekleyecek etmenlerin belirlenmesinin obezite tedavisinde başarıyı artırabileceği öngörülmektedir. Kahve, yüksek orandaki fenolik bileşen ve kafein içeriğinden dolayı bu destekleyici faktörler arasında yer almaktadır. Kahve (Rubiaceae familyası, Coffea cinsi), genellikle tropikal iklimlerde yetişmekte olan bir bitki olup, bu bitkinin meyvelerinin çekirdeklerinden üretilen kahve içecek olarak tüketilmekte ve dünyada en çok tüketilen içecekler arasında yer almaktadır. Kahve, antioksidan bileşenlerden başta klorojenik asit esterlerinden kafeik asit ve kinik asit açısından zengin, kafein içeriği yüksek bir içecektir. Bu bileşiminin katkısıyla sağlık üzerine olumlu etkiler göstermektedir. Güncel veriler kahvenin adipozitenin baskılanması ve vücut ağırlığının azalması üzerine olumlu etkileri olduğunu bildirmektedir. Kahve ve kahve bileşenlerinin obezite üzerine olumlu etkilerini gösterdiği olası mekanizmalar, genlerin modülasyonu yoluyla yağ asidi β-oksidasyonunu, lipolitik ve termojenik etki, kahverengi yağ dokunun aktivasyonu, peroksizom proliferatör aktifleştirici reseptör-γ ekspresyonunun uyarılması şeklindedir. Hayvan çalışmaları, tamamına yakınında kahvenin obezite üzerine olumlu etkilerini rapor ederken, insan çalışmalarının çoğunda olumlu etki, bir kısmında ise olumsuz etkiler saptanmıştır. Ancak insan çalışmalarının gözlemsel nitelikte olması, doza bağımlı sorgulama yapılmaması, kahve türüne dair özel sorgulama yapılmaması öneri geliştirmeyi zorlaştırmaktadır. Bu çalışmada, mevcut çalışmaların derlenmesi ve güncel verilerin ortaya konulması amaçlanmaktadır.

Anahtar Kelimeler: Kafein; kahve; klorojenik asit; obezite; vücut ağırlığı
ABSTRACT
 Obesity is a chronic disease characterized by excessive or abnormal fat accumulation in the body. Medical nutrition therapy and lifestyle changes are the mainstay in obesity treatment. However, in recent years, determining the factors that support obesity treatment may increase the success of obesity treatment. Coffee is one of these supportive therapies due to its high content of phenolic compounds and caffeine. Coffee (Rubiaceae family, Coffea genus) is a plant that grows in tropical climates which is rich in chlorogenic acid esters, caffeic acid, cinnic acid, and caffeine. It has positive effects on health with the contribution of this composition. Recent data suggest that coffee has positive effects on suppression of adiposity and reduction in body weight. The possible mechanisms by that coffee and coffee constituents demonstrate positive effects on obesity include fatty acid β-oxidation by modulation of genes, lipolytic and thermogenic effect, activation of brown fat tissue, and stimulation of peroxisome proliferating activator receptor-γ expression. Almost all animal studies have reported the positive effects of coffee on obesity, whereas in most human studies positive effects have been identified and in some others negative effects. However, the fact that human studies are observational, no dose-dependent questioning, and no specific questioning about the type of coffee makes it difficult to develop suggestions. In this study, it is aimed to compile the current studies and present the current data.

Keywords: Caffeine; coffee; chlorogenic acid; obesity; body weight
REFERENCES:
  1. Pozza C, Isidor AM. What's behind the obesity epidemic. In: Laghi A, Rengo M, eds. Imaging in Bariatric Surgery. 1st ed. Cham: Springer, International Publishing; 2018. p.1-8. [Crossref] 
  2. Sutin AR, Boutelle K, Czajkowski SM, Epel ES, Green PA, Hunter CM, et al. Accumulating data to optimally predict obesity treatment (ADOPT) core measures: psychosocial domain. Obesity (Silver Spring). 2018;26 Suppl 2:S45-54. [Crossref]  [PubMed]  [PMC] 
  3. Rao SP, Krishnamurthy V. Herbal approach for the management of obesity-A review. Int J Pure App Biosci. 2018;6(1):147-58. [Crossref] 
  4. Halvorsen BL, Carlsen MH, Phillips KM, Bøhn SK, Holte K, Jacobs DR, et al. Content of redox-active compounds (i.e. antioxidants) in foods consumed in the United States. Am J Clin Nutr. 2006;84(1):95-135. [Crossref]  [PubMed] 
  5. Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res. 2007;55(3):187-98. [Crossref]  [PubMed] 
  6. Choi BK, Park SB, Lee DR, Lee HJ, Jin YY, Yang SH, et al. Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-induced obese mice. Asian Pac J Trop Med. 2016;9(7):635-43. [Crossref]  [PubMed] 
  7. Saab S, Mallam D, Cox Li GA, Tong MJ. Impact of coffee on liver diseases: a systematic review. Liver Int. 2014;34(4):495-504. [Crossref]  [PubMed] 
  8. O'Keefe JH, Bhatti SK, Patil HR, DiNicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol. 2013;62(12):1043-51. [Crossref]  [PubMed] 
  9. Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V, et al. High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57(1):51-64. [Crossref]  [PubMed] 
  10. Nilsson C, Raun K, Yan FF, Larsen MO, Tang-Christensen M. Laboratory animals as surrogate models of human obesity. Acta Pharmacol Sin. 2012;33(2):173-81. [Crossref]  [PubMed]  [PMC] 
  11. Speakman J, Hambly C, Mitchell S, Król E. The contribution of animal models to the study of obesity. Lab Anim. 2008;42(4):413-32. [Crossref]  [PubMed] 
  12. Sözlü S, Yılmaz B, Acar Tek N. [Coffee consumption and relation with some diseases]. SDÜ Sağlık Bilimleri Enstitüsü Dergisi. 2017;8(2):33-9.
  13. Cano-Marquina A, Tarín JJ, Cano A. The impact of coffee on health. Maturitas. 2013;75(1):7-21. [Crossref]  [PubMed] 
  14. Gonzalez de Mejia E, Ramirez-Mares MV. Impact of caffeine and coffee on our health. Trends Endocrinol Metab. 2014;25(10):489-92. [Crossref]  [PubMed] 
  15. European Food Safety Authority (EFSA). Scientific Opinion on the safety of caffeine. EFSA J. 2015;13(5). [Crossref] 
  16. Camandola S, Plick N, Mattson MP. Impact of coffee and cacao purine metabolites on neuroplasticity and neurodegenerative disease. Neurochem Res. 2019;44(1):214-27. [Crossref]  [PubMed]  [PMC] 
  17. Shin H, Linton JA, Kwon Y, Jung Y, Oh B, Oh S. Relationship between coffee consumption and metabolic syndrome in Korean adults: data from the 2013-2014 Korea national health and nutrition examination survey. Korean J Fam Med. 2017;38(6):346-51. [Crossref]  [PubMed]  [PMC] 
  18. Takami H, Nakamoto M, Uemura H, Katsuura S, Yamaguchi M, Hiyoshi M, et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. J Epidemiol. 2013;23(1):12-20. [Crossref]  [PubMed]  [PMC] 
  19. Demirtas C, Ofluoğlu E, Hussein A, Paşaoğlu H. Efects of caffeine on oxidant-antioxidant mechanisms in the rat liver. Gazi Med J. 2012;23(1):13-8. [Crossref] 
  20. Akash MS, Rehman K, Rehman K, Chen S. Effects of coffee on type 2 diabetes mellitus. Nutrition. 2014;30(7-8):755-63. [Crossref]  [PubMed] 
  21. Cowan TE, Palmnäs MS, Yang J, Bomhof MR, Ardell KL, Reimer RA, et al. Chronic coffee consumption in the diet-induced obese rat: impact on gut microbiota and serum metabolomics. J Nutr Biochem. 2014;25(4):489-95. [Crossref]  [PubMed] 
  22. Uzogara SG. Obesity epidemic, medical and quality of life consequences: a review. Int J Public Health Res. 2017;5(1):1-12.
  23. Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, et al. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol. 2010;48(3):937-43. [Crossref]  [PubMed] 
  24. Panchal SK, Poudyal H, Waanders J, Brown L. Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. J Nutr. 2012;142(4):690-7. [Crossref]  [PubMed] 
  25. Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006;6:9. [Crossref]  [PubMed]  [PMC] 
  26. Abdel Raoof F, Mohamed KY, Mohamed KM. Phytochemical evaluation, anti-obesity and antihyperlipidemic effects of combined administration of green coffee, cinnamon and ginger. Plant. 2017;5(5):80-4. [Crossref] 
  27. Mazzone G, Lembo V, D'Argenio G, Vitaglione P, Rossi A, Guarino M, et al. Decaffeinated coffee consumption induces expression of tight junction proteins in high fat diet fed rats. Funct Food Health Dis. 2016;6(9):602-11. [Crossref] 
  28. Huang CC, Tung YT, Huang WC, Chen YM, Hsu YJ, Hsu M. Beneficial effects of cocoa, coffee, green tea, and garcinia complex supplement on diet induced obesity in rats. BMC Complement Altern Med. 2016;12(16):100. [Crossref]  [PubMed]  [PMC] 
  29. Kim JH, Park YS. Light coffee consumption is protective against sarcopenia, but frequent coffee consumption is associated with obesity in Korean adults. Nutr Res. 2017;41:97-102. [Crossref]  [PubMed] 
  30. Nordestgaard AT, Thomsen M, Nordestgaard BG. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol. 2015;44(2):551-65. [Crossref]  [PubMed] 
  31. Lee CB, Yu SH, Kim NY, Kim SM, Kim SR, Oh SJ, et al. Association between coffee consumption and circulating levels of adiponectin and leptin. J Med Food. 2017;20(11):1068-75. [Crossref]  [PubMed] 
  32. Grosso G, Stepaniak U, Micek A, Topor-Mądry R, Pikhart H, Szafraniec K, et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr. 2015;54(7):1129-37. [Crossref]  [PubMed]  [PMC] 
  33. Nurwanti E, Bai CH. A population-based study of sedentary behavior, coffee and caffeine intake, education level associated with obesity risk among young adult. P Nutr Soc. 2018;77(OCE4):(E184). [Crossref] 
  34. Grosso G, Marventano S, Galvano F, Pajak A, Mistretta A. Factors associated with metabolic syndrome in a mediterranean population: role of caffeinated beverages. J Epidemiol. 2014;24(4):327-33. [Crossref]  [PubMed]  [PMC] 
  35. Balk L, Hoekstra T, Twisk J. Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol. 2009;24(4):203-9. [Crossref]  [PubMed] 
  36. Arciero PJ, Bougopoulas CL, Nindl BC, Benowitz NL. Influence of age on the thermic response to caffeine in women. Metabolism. 2000;49(1):101-7. [Crossref] 
  37. Haidari F, Samadi M, Mohammadshahi M, Jalali MT, Engali KA. Energy restriction combined with green coffee bean extract affects serum adipocytokines and the body composition in obese women. Asia Pac J Clin Nutr. 2017;26(6):1048-54.
  38. Lopez-Garcia E, Guallar-Castillon P, Leon-Mu-oz L, Graciani A, Rodriguez-Artalejo F. Coffee consumption and health-related quality of life. Clin Nutr. 2014;33(1):143-9. [Crossref]  [PubMed] 
  39. Hino A, Adachi H, Enomoto M, Furuki K, Shigetoh Y, Ohtsuka M, et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res Clin Pract. 2007;76(3):383-9. [Crossref]  [PubMed] 
  40. Schubert MM, Irwin C, Seay RF, Clarke HE, Allegro D, Desbrow B. Caffeine, coffee, and appetite control: a review. Int J Food Sci Nutr. 2017;68(8):901-12. [Crossref]  [PubMed] 
  41. Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol. 2012;22(2):160-6. [Crossref]  [PubMed]  [PMC] 
  42. Lee A, Lim W, Kim S, Khil H, Cheon E, An S, et al. Coffee intake and obesity: a meta-analysis. Nutrients. 2019;11(6). [Crossref]  [PubMed]  [PMC] 
  43. Velickovic K, Wayne D, Leija HAL, Bloor I, Morris DE, Law J, et al. Caffeine exposure induces browning features in adipose tissue in vitro and in vivo. Sci Rep. 2019;9(1):9104. [Crossref]  [PubMed]  [PMC] 
  44. Martins I. Caffeine consumption and induction of obesity in the developed world. Ann Obes Relat Dis. 2017;2(1):1018.
  45. Jessen A, Buemann B, Toubro S, Skovgaard IM, Astrup A. The appetite-suppressant effect of nicotine is enhanced by caffeine. Diabetes Obes Metab. 2005;7(4):327-33. [Crossref]  [PubMed] 
  46. Schubert MM, Grant G, Horner K, King N, Leveritt M, Sabapathy S, et al. Coffee for morning hunger pangs. An examination of coffee and caffeine on appetite, gastric emptying, and energy intake. Appetite. 2014;83:317-26. [Crossref]  [PubMed] 
  47. Pettenuzzo LF, Noschang C, von Pozzer Toigo E, Fachin A, Vendite D, Dalmaz C. Effects of chronic administration of caffeine and stress on feeding behavior of rats. Physiol Behav. 2008;95(3):295-301. [Crossref]  [PubMed] 
  48. Gupta BS, Gupta U. Caffeine and Behavior: Current Views and Research Trends. 1st ed. Florida: CRC Press; 1999. [Crossref] 
  49. Wang T, Huang T, Kang JH, Zheng Y, Jensen MK, Wiggs JL, et al. Habitual coffee consumption and genetic predisposition to obesity: gene-diet interaction analyses in three US prospective studies. BMC Med. 2017;15(1):97. [Crossref]  [PubMed]  [PMC] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com